×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agendas
Session 0501 Drug Safety in Clinical Development – Benefit / Risk Based Decision
Session Chair(s)
Yuan Meng
Director, Associate Safety Risk Lead (Associate SR
Pfizer (China) Research and Development Co.,Ltd, China
Speaker(s)
Mason Shih
Genentech, a Member of Roche Group, China
Site Head, Drug Safety, Asia Pacific
Safety Surveillance& Risk Management in Drug Development
Ayman Ayoub, MD, MSc
Pfizer LTD Central Research, United Kingdom
Executive Director
The Value of Drug Safety in Drug Development
Mason Shih
Genentech, a Member of Roche Group, China
Site Head, Drug Safety, Asia Pacific
Have an account?